Aromatic Amines and Heterocyclic Aromatic Amines: From Tobacco Smoke to Food Mutagens

The Chemical Biology of DNA Damage

Volumn , Issue , 2010, Pages 157-183

  Turesky, Robert J ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

Aromatic amine; Cancer epidemiology; Food mutagen; Heterocyclic aromatic amine; Mutagenesis; Oncogene; Tobacco smoke

Indexed keywords

EID: 80455149266     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527630110.ch7     Document Type: Chapter

References (156)

1. Weisburger, J.H. and Weisburger, E.K. (1966) Chemicals as causes of cancer. Chem. Eng. News, 44, 124-142.
2. Rehn, L. (1895) Blasengeschwulste bei Fuchsinarbeitern. Arch. Klin. Chir., 50, 588-600.
3. Clayson, D.B. (1981) Specific aromatic amines as occupational bladder carcinogens. Natl. Cancer Inst. Monogr., 15-19.
4. Vineis, P. and Pirastu, R. (1997) Aromatic amines and cancer. Cancer Causes Control, 8, 346-355.
5. Rothman, N., Bhatnagar, V.K., Hayes, R.B., Zenser, T.V., Kashyap, S.K., Butler, M.A., Bell, D.A., Lakshmi, V., Jaeger, M., Kashyap, R., Hirvonen, A., Schulte, P.A., Dosemeci, M., Hsu, F., Parikh, D.J., Davis, B.B., and Talaska, G. (1996) The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc. Natl. Acad. Sci. USA, 93, 5084-5089.
6. Heflich, R.H. and Neft, R.E. (1994) Genetic toxicity of 2-acetylaminoflu orene, 2-aminofluorene and some of their metabolites and model metabolites. Mutat. Res., 318, 73-114.
7. Hoffmann, G.R. and Fuchs, R.P. (1997) Mechanisms of frameshift mutations: insight from aromatic amines. Chem. Res. Toxicol., 10, 347-359.
8. Neumann, H.G. (2007) Aromatic amines in experimental cancer research: tissue-specific effects, an old problem and new solutions. Crit. Rev. Toxicol., 37, 211-236.
9. Stavric, B., Klassen, R., and Miles, W. (1979) Gas-liquid chromatographic-mass spectrometric determination of alpha-and beta-naphthylamines in FD & C Red No. 2 (amaranth). J. Assoc. Off. Anal. Chem., 62, 1020-1026.
10. Davis, V.M. and Bailey, J.E., Jr. (1993) Chemical reduction of FD & C yellow No. 5 to determine combined benzidine. J. Chromatogr., 635, 160-164.
11. Garrigos, M.C., Reche, F., Marin, M.L., and Jimenez, A. (2002) Determination of aromatic amines formed from azo colorants in toy products. J. Chromatogr. A, 976, 309-317.
12. Lancaster, F.E. and Lawrence, J.F. (1999) Determination of benzidine in the food colours tartrazine and sunset yellow FCF, by reduction and derivatization followed by high-performance liquid chromatography. Food Addit. Contam., 16, 381-390.
13. Oh, S.W., Kang, M.N., Cho, C.W., and Lee, M.W. (1997) Detection of carcinogenic amines from dyestuffs or dyed substrates. Dyes Pigments, 33, 119-135.
14. Cioni, F., Bartolucci, G., Pieraccini, G., Meloni, S., and Moneti, G. (1999) Development of a solid phase microextraction method for detection of the use of banned azo dyes in coloured textiles and leather. Rapid Commun. Mass Spectrom., 13, 1833-1837.
15. Chiang, T.A., Pei-Fen, W., Ying, L.S., Wang, L.F., and Ko, Y.C. (1999) Mutagenicity and aromatic amine content of fumes from heated cooking oils produced in Taiwan. Food Chem. Toxicol., 37, 125-134.
16. Tokiwa, H., Nakagawa, R., and Horikawa, K. (1985) Mutagenic/carcinogenic agents in indoor pollutants; the dinitropyrenes generated by kerosene heaters and fuel gas and liquefied petroleum gas burners. Mutat. Res., 157, 39-47.
17. Patrianakos, C. and Hoffmann, D. (1979) Chemical studies on tobacco smoke LXIV. On the analysis of aromatic amines in cigarette smoke. J. Assoc. Off. Anal. Chem., 3, 150-154.
18. Turesky, R.J., Freeman, J.P., Holland, R.D., Nestorick, D.M., Miller, D.W., Ratnasinghe, D.L., and Kadlubar, F.F. (2003) Identification of aminobiphenyl derivatives in commercial hair dyes. Chem. Res. Toxicol., 16, 1162-1173.
19. Akyuz, M. and Ata, S. (2008) Determination of aromatic amines in hair dye and henna samples by ion-pair extraction and gas chromatography-mass spectrometry. J. Pharm. Biomed. Anal., 47, 68-80.
20. Sugimura, T., Nagao, N., Kawachi, T., Honda, M., Yahagi, T., Seino, Y., Stao, S., Matsukura, N., Matsushima, T., Shirai, A., Sawamura, M., and Matsumoto, H. (1977) Mutagen-carcinogens in food, with special reference to highly mutagenic pyrolytic products in broiled foods, in Origins of Human Cancer, Book C (eds H.H. Hiatt, J.D. Watson, and J.A. Winstein), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 1561-1577.
21. Sugimura, T., Wakabayashi, K., Nakagama, H., and Nagao, M. (2004) Heterocyclic amines: mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci., 95, 290-299.
22. Knize, M.G. and Felton, J.S. (2005) Formation and human risk of carcinogenic heterocyclic amines formed from natural precursors in meat. Nutr. Rev., 63, 158-165.
23. Jagerstad, M., Skog, K., Grivas, S., and Olsson, K. (1991) Formation of heterocyclic amines using model systems. M utat. Res., 259, 219-233.
24. Manabe, S., Tohyama, K., Wada, O., and Aramaki, T. (1991) Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine, in cigarette smoke condensate. Carcinogenesis, 12, 1945-1947.
25. Shirai, T., Sano, M., Tamano, S., Takahashi, S., Hirose, M., Futakuchi, M., Hasegawa, R., Imaida, K., Matsumoto, K., Wakabayashi, K., Sugimura, T., and Ito, N. (1997) The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine (PhIP) derived from cooked foods. Cancer Res., 57, 195-198.
26. Glatt, H. (2006) Metabolic factors affecting the mutagenicity of heterocyclic amines, in Acrylamide and Other Hazardous Compounds in Heat-Treated Foods (eds K. Skog and J. Alexander), Woodhead, Cambridge, pp. 358-404.
27. Butler, M.A., Iwasaki, M., Guengerich, F.P., and Kadlubar, F.F. (1989) Human cytochrome P-450 PA (P450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA, 86, 7696-7700.
28. Turesky, R.J. (2005) Interspecies metabolism of heterocyclic aromatic amines and the uncertainties in extrapolation of animal toxicity data for human risk assessment. Mol. Nutr. Food Res., 49, 101-117.
29. Shimada, T. and Guengerich, F.P. (1991) Activation of amino-α-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine, and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes. Cancer Res., 51, 5284-5291.
30. Josephy, P.D. (1996) The role of peroxidase-catalyzed activation of aromatic amines in breast cancer. Mutagenesis, 11, 3-7.
31. Beland, F.A., Beranek, D.T., Dooley, K.L., Heflich, R.H., and Kadlubar, F.F. (1983) Arylamine-DNA adducts in vitro and in vivo : their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environ. Health Perspect., 49, 125-134.
32. Schut, H.A. and Snyderwine, E.G. (1999) DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis, 20, 353-368.
33. Turesky, R.J. (2004) The role of genetic polymorphisms in metabolism of carcinogenic heterocyclic aromatic amines. Curr. Drug Metab., 5, 169-180.
34. Conney, A.H. (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res., 42, 4875-4917.
35. Sinha, R., Rothman, N., Brown, E.D., Mark, S.D., Hoover, R.N., Caporaso, N.E., Levander, O.A., Knize, M.G., Lang, N.P., and Kadlubar, F.F. (1994) Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in humans. Cancer Res., 54, 6154-6159.
36. Hammons, G.J., Yan-Sanders, Y., Jin, B., Blann, E., Kadlubar, F.F., and Lyn-Cook, B.D. (2001) Specific site methylation in the 5 ′-flanking region of CYP1A2 interindividual differences in human livers. Life Sci., 69, 839-845.
37. Nakajima, M., Yokoi, T., Mizutani, M., Kinoshita, M., Funayama, M., and Kamataki, T. (1999) Genetic polymorphism in the 5 ′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J. Biochem., 125, 803-808.
38. Sachse, C., Bhambra, U., Smith, G., Lightfoot, T.J., Barrett, J.H., Scollay, J., Garner, R.C., Boobis, A.R., Wolf, C.R., and Gooderham, N.J. (2003) Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br. J. Clin. Pharmacol., 55, 68-76.
39. Belloc, C., Baird, S., Cosme, J., Lecoeur, S., Gautier, J.-C., Challine, D., de Waziers, I., Flinois J.-P., and Beaune, P.H. (1996) Human cytochrome P450 expressed in Escherichia coli : production of specific antibodies. Toxicology, 106, 207-219.
40. Turesky, R.J., Constable, A., Richoz, J., Varga, N., Markovic, J., Martin, M.V., and Guengerich, F.P. (1998) Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2. Chem. Res. Toxicol., 11, 925-936.
41. Turesky, R.J., Parisod, V., Huynh-Ba, T., Langouet, S., and Guengerich, F.P. (2001) Regioselective differences in C 8-and N-oxidation of 2-amino-3,8-dimethylimidazo[4,5-f ]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2. Chem. Res. Toxicol., 14, 901-911.
42. Hein, D.W., Doll, M.A., Fretland, A.J., Leff, M.A., Webb, S.J., Xiao, G.H., Devanaboyina, U.S., Nangju, N.A., and Feng, Y. (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev., 9, 29-42.
43. Hein, D.W. (2002) Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat. Res., 506-507, 65-77.
44. Hein, D.W. (2006) N-Acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene, 25, 1649-1658.
45. Cohen, S.M., Boobis, A.R., Meek, M.E., Preston, R.J., and McGregor, D.B. (2006) 4-Aminobiphenyl and DNA reactivity: case study within the context of the 2006 IPCS human relevance framework for analysis of a cancer mode of action for humans. Crit. Rev. Toxicol., 36, 803-819.
46. Kennelly, J.C., Beland, F.A., Kadlubar, F.F., and Martin, C.N. (1984) Binding of N-acetylbenzidine and N, N ′-diacetylbenzidine to hepatic DNA of rat and hamster in vivo and in vitro. Carcinogenesis, 5, 407-412.
47. Garcia-Closas, M., Malats, N., Silverman, D., Dosemeci, M., Kogevinas, M., Hein, D.W., Tardon, A., Serra, C., Carrato, A., Garcia-Closas, R., Lloreta, J., Castano-Vinyals, G., Yeager, M., Welch, R., Chanock, S., Chatterjee, N., Wacholder, S., Samanic, C., Tora, M., Fernandez, F., Real, F.X., and Rothman, N. (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet, 366, 649-659.
48. Hein, D.W. (2000) N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol. Lett., 112-113, 349-356.
49. Lang, N.P., Butler, M.A., Massengill, J.P., Lawson, M., Stotts, R.C., Hauer-Jensen, M., and Kadlubar, F.F. (1994) Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prev., 3, 675-682.
50. Le Marchand, L., Hankin, J.H., Wilkens, L.R., Pierce, L.M., Franke, A., Kolonel, L.N., Seifried, A., Custer, L.J., Chang, W., Lum-Jones, A., and Donlon, T. (2001) Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev., 10, 1259-1266.
51. Nowell, S. and Falany, C.N. (2006) Pharmacogenetics of human cytosolic sulfotransferases. O ncogene, 25, 1673-1678.
52. Lewis, A.J., Walle, U.K., King, R.S., Kadlubar, F.F., Falany, C.N., and Walle, T. (1998) Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b ] pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells. Carcinogenesis, 19, 2049-2053.
53. Raftogianis, R.B., Wood, T.C., and Weinshilboum, R.M. (1999) Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem. Pharmacol., 58, 605-616.
54. Zheng, W., Xie, D., Cerhan, J.R., Sellers, T.A., Wen, W., and Folsom, A.R. (2001) Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 10, 89-94.
55. Nowell, S., Ambrosone, C.B., Ozawa, S., MacLeod, S.L., Mrackova, G., Williams, S., Plaxco, J., Kadlubar, F.F., and Lang, N.P. (2000) Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol. Pharmacogenetics, 10, 789-797.
56. Moreno, V., Glatt, H., Guino, E., Fisher, E., Meinl, W., Navarro, M., Badosa, J.M., and Boeing, H. (2005) Polymorphisms in sulfotransferases SULT1A1 and SULT1A2 are not related to colorectal cancer. Int. J. Cancer, 113, 683-686.
57. Steiner, M., Bastian, M., Schulz, W.A., Pulte, T., Franke, K.H., Rohring, A., Wolff, J.M., Seiter, H., and Schuff-Werner, P. (2000) Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of association. Arch. Toxicol., 74, 222-225.
58. Turesky, R.J., Lang, N.P., Butler, M.A., Teitel, C.H., and Kadlubar, F.F. (1991) Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis, 12, 1839-1845.
59. Frandsen, H., Grivas, S., Andersson, R., Dragsted, L., and Larsen, J.C. (1992) Reaction of the N 2-acetoxy derivative of 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine (PhIP) with 2 ′-deoxyguanosine and DNA. Synthesis and identification of N 2-(2 ′-deoxyguanosin-8-yl)-PhIP. Carcinogenesis, 13, 629-635.
60. Kaderlik, K.R., Mulder, G.J., Turesky, R.J., Lang, N.P., Teitel, C.H., Chiarelli, M.P., and Kadlubar, F.F. (1994) Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes. Carcinogenesis, 15, 1701.
61. Styczynski, P.B., Blackmon, R.C., Groopman, J.D., and Kensler, T.W. (1993) The direct glucuronidation of 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine (PhIP) by human and rabbit liver microsomes. Chem. Res. Toxicol., 6, 846-851.
62. Snyderwine, E.G., Turesky, R.J., Turteltaub, K.W., Davis, C.D., Sadrieh, N., Schut, H.A., Nagao, M., Sugimura, T., Thorgeirsson, U.P., Adamson, R.H., and Thorgeirsson, S.S. (1997) Metabolism of food-derived heterocyclic amines in nonhuman primates. Mutat. Res., 376, 203-210.
63. Humphreys, W.G., Kadlubar, F.F., and Guengerich, F.P. (1992) Mechanism of C8 alkylation of guanine residues by activated arylamines: evidence for initial adduct formation at the N 7 position. Proc. Natl. Acad. Sci. USA, 89, 8278-8282.
64. Kennedy, S.A., Novak, M., and Kolb, B.A. (1997) Reactions of ester derivatives of carcinogenic N-(4-biphenylyl) hydroxylamine and the corresponding hydroxa mic acid with purine nucleosides. J. Am. Chem. Soc., 119, 7654-7664.
65. Turesky, R.J., Rossi, S.C., Welti, D.H., O'Lay, J., Jr., and Kadlubar, F.F. (1992) Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f ] quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f ]quinoxaline at the C-8 and N 2 atoms of guanine. Chem. Res. Toxicol., 5, 479-490.
66. Jamin, E.L., Arquier, D., Canlet, C., Rathahao, E., Tulliez, J., and Debrauwer, L. (2007) New insights in the formation of deoxynucleoside adducts with the heterocyclic aromatic amines PhIP and IQ by means of ion trap MS n and accurate mass measurement of fragment ions. J. Am. Soc. Mass Spectrom., 18, 2107-2118.
67. Elmquist, C.E., Stover, J.S., Wang, Z., and Rizzo, C.J. (2004) Site-specific synthesis and properties of oligonucleotides containing C8-deoxyguanosine adducts of the dietary mutagen IQ. J. Am. Chem. Soc., 126, 11189-11201.
68. Stover, J.S. and Rizzo, C.J. (2007) Synthesis of oligonucleotides containing the N 2-deoxyguanosine adduct of the dietary carcinogen 2-amino-3-methylimidazo[4,5-f ]quinoline. Chem. Res. Toxicol., 20, 1972-1979.
69. Bonala, R., Torres, M.C., Iden, C.R., and Johnson, F. (2006) Synthesis of the PhIP adduct of 2 ′-deoxyguanosine and its incorporation into oligomeric DNA. Chem. Res. Toxicol., 19, 734-738.
70. Lakshman, M.K. (2005) Synthesis of biologically important nucleoside analogs by palladium-catalyzed C-N bond formation. Cur. Org. Synth., 2, 83-112.
71. Broyde, S., Wang, L., Zhang, L., Rechkoblit, O., Geacintov, N.E., and Patel, D.J. (2008) DNA adduct structure-function relationships: comparing solution with polymerase structures. C hem. Res. Toxicol., 21, 45-52.
72. Delaney, J.C. and Essigmann, J.M. (2008) Biological properties of single chemical-DNA adducts: a twenty year perspective. Chem. Res. Toxicol., 21, 232-252.
73. Patel, D.J., Mao, B., Gu, Z., Hingerty, B.E., Gorin, A., Basu, A.K., and Broyde, S. (1998) Nuclear magnetic resonance solution structures of covalent aromatic amine-DNA adducts and their mutagenic relevance. Chem. Res. Toxicol., 11, 391-407.
74. Lukin, M. and de Los, S.C. (2006) NMR structures of damaged DNA. Chem. Rev., 106, 607-686.
75. Zaliznyak, T., Bonala, R., Johnson, F., and de Los, S.C. (2006) Structure and stability of duplex DNA containing the 3-(deoxyguanosin-N 2-yl)-2-acetylaminofluorene (dG(N 2)-AAF) lesion: a bulky adduct that persists in cellular DNA. Chem. Res. Toxicol., 19, 745-752.
76. Brown, K., Hingerty, B.E., Guenther, E.A., Krishnan, V.V., Broyde, S., Turteltaub, K.W., and Cosman, M. (2001) Solution structure of the 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine C8-deoxyguanosine adduct in duplex DNA. Proc. Natl. Acad. Sci. USA, 98, 8507-8512.
77. Wang, F., DeMuro, N.E., Elmquist, C.E., Stover, J.S., Rizzo, C.J., and Stone, M.P. (2006) Base-displaced intercalated structure of the food mutagen 2-amino-3-methylimidazo[4,5-f ] quinoline in the recognition sequence of the Nar I restriction enzyme, a hotspot for-2 bp deletions. J. Am. Chem. Soc., 128, 10085-10095.
78. Choi, J.Y., Stover, J.S., Angel, K.C., Chowdhury, G., Rizzo, C.J., and Guengerich, F.P. (2006) Biochemical basis of genotoxicity of heterocyclic arylamine food mutagens: human DNA polymerase η selectively produces a two-base deletion in copying the N 2-guanyl adduct of 2-amino-3-methylimidazo[4,5-f ]quinoline but not the C8 adduct at the Nar I G3 site. J. Biol. Chem., 281, 25297-25306.
79. Stover, J.S., Chowdhury, G., Zang, H., Guengerich, F.P., and Rizzo, C.J. (2006) Translesion synthesis past the C8-and N 2-deoxyguanosine adducts of the dietary mutagen 2-Amino-3-methylimidazo[4,5-f ]quinoline in the Nar I recognition sequence by prokaryotic DNA polymerases. Chem. Res. Toxicol., 19, 1506-1517.
80. Shibutani, S., Fernandes, A., Suzuki, N., Zhou, L., Johnson, F., and Grollman, A.P. (1999) Mutagenesis of the N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine DNA adduct in mammalian cells. Sequence context effects. J. Biol. Chem., 274, 27433-27438.
81. Culp, S.J., Poirier, M.C., and Beland, F.A. (1993) Biphasic removal of DNA adducts in a repetitive DNA sequence after dietary administration of 2-acetylaminofluorene. Environ. Health Perspect., 99, 273-275.
82. Turesky, R.J., Box, R.M., Markovic, J., Gremaud, E., and Snyderwine, E.G. (1997) Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f ]quinoline in the rat and nonhuman primates. Mutat. Res., 376, 235-241.
83. Beland, F.A. and Kadlubar, F.F. (1985) Formation and persistence of arylamine DNA adducts in vivo. Environ. Health Perspect., 62, 19-30.
84. Chung, K.T., Chen, S.C., Wong, T.Y., Li, Y.S., Wei, C.I., and Chou, M.W. (2000) Mutagenicity studies of benzidine and its analogs: structure-activity relationships. Toxicol. Sci., 56, 351-356.
85. Felton, J.S., Knize, M.G., Dolbeare, F.A., and Wu, R. (1994) Mutagenic activity of heterocyclic amines in cooked food. Environ. Health Perspect., 102 (Suppl. 6), 201-204.
86. Fuscoe, J.C., Wu, R., Shen, N.H., Healy, S.K., and Felton, J.S. (1988) Base-change analysis of revertants of the hisD3052 allele in Salmonella typhimurium. Mutat. Res., 201, 241-251.
87. Josephy, P.D. (2000) The Escherichia coli lacZ reversion mutagenicity assay. Mutat. Res., 455, 71-80.
88. Metry, K.J., Zhao, S., Neale, J.R., Doll, M.A., States, J.C., McGregor, W.G., Pierce, W.M., Jr., and Hein, D.W. (2007) 2-Amino-1-methyl-6-phenylimidazo [4,5-b ] pyridine-induced DNA adducts and genotoxicity in Chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N-acetyltransferase 2. Mol. Carcinog., 46, 553-563.
89. Wu, R.W., Tucker, J.D., Sorensen, K.J., Thompson, L.H., and Felton, J.S. (1997) Differential effect of acetyltransferase expression on the genotoxicity of heterocyclic amines in CHO cells. Mutat. Res., 390, 93-103.
90. Morgenthaler, P.M. and Holzhauser, D. (1995) Analysis of mutations induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine (PhIP) in human lymphoblastoid cells. Carcinogenesis, 16, 713-718.
91. Carothers, A.M., Yuan, W., Hingerty, B.E., Broyde, S., Grunberger, D., and Snyderwine, E.G. (1994) Mutation and repair induced by the carcinogen 2-(hydroxyamino)-1-methyl-6-phenylimidazo[4,5-b ]pyridine (N-OH-PhIP) in the dihydrofolate reductase gene of Chinese hamster ovary cells and conformational modeling of the dG-C8-PhIP adduct in DNA. Chem. Res. Toxicol., 7, 209-218.
92. Wu, R.W., Wu, E.M., Thompson, L.H., and Felton, J.S. (1995) Identification of aprt gene mutations induced in repair-deficient and P450-expressing CHO cells by the food-related mutagen/carcinogen, PhIP. Carcinogenesis, 16, 1207-1213.
93. Yadollahi-Farsani, M., Gooderham, N.J., Davies, D.S., and Boobis, A.R. (1996) Mutational spectra of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine (PhIP) at the Chinese hamsters hprt locus. Carcinogenesis, 17, 617-624.
94. Kakiuchi, H., Watanabe, M., Ushijima, T., Toyota, M., Imai, K., Weisburger, J.H., Sugimura, T., and Nagao, N. (1995) Specific 5 ′-GGGA-3 ′ → 5 ′-GGA-3 ′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine. Proc. Natl. Acad. Sci. USA, 92, 910-914.
95. Leong-Morgenthaler, P.M., Op, H.V., Jaccaud, E., and Turesky, R.J. (1998) Mutagenicity of 2-amino-3-methylimidazo[ 4,5-f ]quinoline in human lymphoblastoid cells. Carcinogenesis, 19, 1749-1754.
96. Bookland, E.A., Reznikoff, C.A., Lindstrom, M., and Swaminathan, S. (1992) Induction of thioguanine-resistant mutations in human uroepithelial cells by 4-aminobiphenyl and its N-hydroxy derivatives. Cancer Res., 52, 1615-1621.
97. Bol, S.A., Horlbeck, J., Markovic, J., de Boer, J.G., Turesky, R.J., and Constable, A. (2000) Mutational analysis of the liver, colon and kidney of Big Blue rats treated with 2-amino-3-methylimidazo[4,5-f ]quinoline. Carcinogenesis, 21, 1-6.
98. Moller, P., Wallin, H., Vogel, U., Autrup, H., Risom, L., Hald, M.T., Daneshvar, B., Dragsted, L.O., Poulsen, H.E., and Loft, S. (2002) Mutagenicity of 2-amino-3-methylimidazo[4,5-f ] quinoline in colon and liver of Big Blue rats: role of DNA adducts, strand breaks, DNA repair and oxidative stress. Carcinogenesis, 23, 1379-1385.
99. Nagao, M., Ochiai, M., Okochi, E., Ushijima, T., and Sugimura, T. (2001) LacI transgenic animal study: relationships among DNA-adduct levels, mutant frequencies and cancer incidences. M utat. Res., 477, 119-124.
100. Itoh1, T., Suzuki, T., Nishikawa, A., Furukawa, F., Takahashi, M., Xue, W., Sofuni, T., and Hayashi, M. (2000) In vivo genotoxicity of 2-amino-3,8-dimethylimidazo[ 4, 5-f ]quinoxaline in lacI transgenic (Big Blue) mice. Mutat. Res., 468, 19-25.
101. Lynch, A.M., Gooderham, N.J., and Boobis, A.R. (1996) Organ distinctive mutagenicity in MutaMouse after short-term exposure to PhIP. Mutagenesis, 11, 505-509.
102. Zhang, X.B., Felton, J.S., Tucker, J.D., Urlando, C., and Heddle, J.A. (1996) Intestinal mutagenicity of two carcinogenic food mutagens in transgenic mice: 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine and amino(α)carboline. Carcinogenesis, 17, 2259-2265.
103. Fletcher, K., Tinwell, H., and Ashby, J. (1998) Mutagenicity of the human bladder carcinogen 4-aminobiphenyl to the bladder of MutaMouse transgenic mice. Mutat. Res., 400, 245-250.
104. Okonogi, H., Ushijima, T., Zhang, X.B., Heddle, J.A., Suzuki, T., Sofuni, T., Felton, J.S., Tucker, J.D., Sugimura, T., and Nagao, M. (1997) Agreement of mutational characteristics of heterocyclic amines in lacI of the Big Blue mouse with those in tumor related genes in rodents. Carcinogenesis, 18, 745-748.
105. Nagao, M., Ushijima, T., Toyota, M., Inoue, R., and Sugimura, T. (1997) Genetic changes induced by heterocyclic amines. Mutat. Res., 376, 161-167.
106. Itoh, T., Kuwahara, T., Suzuki, T., Hayashi, M., and Ohnishi, Y. (2003) Regional mutagenicity of heterocyclic amines in the intestine: mutation analysis of the cII gene in lambda/lacZ transgenic mice. Mutat. Res., 539, 99-108.
107. Stuart, G.R., Thorleifson, E., Okochi, E., de Boer, J.G., Ushijima, T., Nagao, M., and Glickman, B.W. (2000) Interpretation of mutational spectra from different genes: analyses of PhIP-induced mutational specificity in the lacI and cII transgenes from colon of Big Blue rats. Mutat. Res., 452, 101-121.
108. Smith-Roe, S.L., Hegan, D.C., Glazer, P.M., and Buermeyer, A.B. (2005) Mlh1-dependent suppression of specific mutations induced in vivo by the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b ]pyridine (PhIP). Mutat. Res., 594, 101-112.
109. Turesky, R.J. and Vouros, P. (2004) Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 802, 155-166.
110. Glaab, W.E., Kort, K.L., and Skopek, T.R. (2000) Specificity of mutations induced by the food-associated heterocyclic amine 2-amino-1-methyl-6-phenylimidazo-[4,5-b ]-pyridine in colon cancer cell lines defective in mismatch repair. Cancer Res., 60, 4921-4925.
111. Chen, T., Mittelstaedt, R.A., Beland, F.A., Heflich, R.H., Moore, M.M., and Parsons, B.L. (2005) 4-Aminobiphenyl induces liver DNA adducts in both neonatal and adult mice but induces liver mutations only in neonatal mice. Int. J. Cancer, 117, 182-187.
112. Melchior, W.B., Jr., Marques, M.M., and Beland, F.A. (1994) Mutations induced by aromatic amine DNA adducts in pBR322. Carcinogenesis, 15, 889-899.
113. Nagao, M. (2000) Mutagenicity, in Food Borne Carcinogens Heterocyclic Amines (eds M. Nagao and T. Sugimura), John Wiley & Sons, Ltd, Chichester, pp. 163-195.
114. Turesky, R.J. (2002) Heterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis. D rug Metab. Rev., 34, 625-650.
115. Lord, P.G., Hardaker, K.J., Loughlin, J.M., Marsden, A.M., and Orton, T.C. (1992) Point mutation analysis of ras genes in spontaneous and chemically induced C57Bl/10J mouse liver tumours. C arcinogenesis, 13, 1383-1387.
116. Olivier, M., Eeles, R., Hollstein, M., Khan, M.A., Harris, C.C., and Hainaut, P. (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum. Mutat., 19, 607-614.
117. Feng, Z., Hu, W., Rom, W.N., Beland, F.A., and Tang, M.S. (2002) 4-Aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis, 23, 1721-1727.
118. Feng, Z., Hu, W., Rom, W.N., Beland, F.A., and Tang, M.S. (2002) N-hydroxy-4-aminobiphenyl-DNA binding in human p53 gene: sequence preference and the effect of C5 cytosine methylation. Biochemistry, 41, 6414-6421.
119. Burnouf, D., Miturski, R., Nagao, M., Nakagama, H., Nothisen, M., Wagner, J., and Fuchs, R.P. (2001) Early detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine (PhIP)-induced mutations within the Apc gene of rat colon. Carcinogenesis, 22, 329-335.
120. Culp, S.J., Roberts, D.W., Talaska, G., Lang, N.P., Fu, P.P., Lay, J.O., Jr., Teitel, C.H., Snawder, J.E., Von Tungeln, L.S., and Kadlubar, F.F. (1997) Immunochemical, 32 P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation. Mutat. Res., 378, 97-112.
121. Faraglia, B., Chen, S.Y., Gammon, M.D., Zhang, Y., Teitelbaum, S.L., Neugut, A.I., Ahsan, H., Garbowski, G.C., Hibshoosh, H., Lin, D., Kadlubar, F.F., and Santella, R.M. (2003) Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke. Carcinogenesis, 24, 719-725.
122. Lin, D., Lay, J.O., Jr., Bryant, M.S., Malaveille, C., Friesen, M., Bartsch, H., Lang, N.P., and Kadlubar, F.F. (1994) Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometr. Environ. Health Perspect., 102 (Suppl. 6), 11-16.
123. Dingley, K.H., Roberts, M.L., Velsko, C.A., and Turteltaub, K.W. (1998) Attomole detection of 3 H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14 C accelerator mass spectrometry. Chem. Res. Toxicol., 11, 1217-1222.
124. Doerge, D.R., Churchwell, M.I., Marques, M.M., and Beland, F.A. (1999) Quantitative analysis of 4-aminobiphenyl-C8-deoxyguanosyl DNA adducts produced in vitro and in vivo using HPLC-ES-MS. Carcinogenesis, 20, 1055-1061.
125. Hatcher, J.F. and Swaminathan, S. (2002) Identification of N-(deoxyguanosin-8-yl)-4-azobiphenyl by 32 P-postlabeling analyses of DNA in human uroepithelial cells exposed to proximate metabolites of the environmental carcinogen 4-aminobiphenyl. Environ. Mol. Mutagen., 39, 314-322.
126. Swaminathan, S. and Hatcher, J.F. (2002) Identification of new DNA adducts in human bladder epithelia exposed to the proximate metabolite of 4-aminobiphenyl using 32 P-postlabeling method. Chem. Biol. Interact., 139, 199-213.
127. Poirier, M.C., Fullerton, N.F., Smith, B.A., and Beland, F.A. (1995) DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels. Carcinogenesis, 16, 2917-2921.
128. Yamazoe, Y., Miller, D.W., Weis, C.C., Dooley, K.L., Zenser, T.V., Beland, F.A., and Kadlubar, F.F. (1985) DNA adducts formed by ring-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo. Carcinogenesis, 6, 1379-1387.
129. Martin, C.N., Beland, F.A., Roth, R.W., and Kadlubar, F.F. (1982) Covalent binding of benzidine and N-acetylbenzidine to DNA at the C-8 atom of deoxyguanosine in vivo and in vitro. Cancer Res., 42, 2678-2686.
130. Yamazoe, Y., Roth, R.W., and Kadlubar, F.F. (1986) Reactivity of benzidine diimine with DNA to form N-(deoxyguanosin-8-yl)-benzidine. Carcinogenesis, 7, 179-182.
131. Pfau, W., Brockstedt, U., Sohren, K.D., and Marquardt, H. (1994) 32 P-Post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification. Carcinogenesis, 15, 877-882.
132. Ochiai, M., Nakagama, H., Turesky, R.J., Sugimura, T., and Nagao, M. (1999) A new modification of the 32 P-post-labeling method to recover IQ-DNA adducts as mononucleotides. Mutagenesis, 14, 239-242.
133. Bessette, E.E., Goodenough, A.K., Langouet, S., Yasa, I., Kozekov, I.D., Spivack, S.D., and Turesky, R.J. (2009) Screening for DNA adducts by data-dependent constant neutral loss-triple stage mass spectrometry with a linear quadrupole ion trap mass spectrometer. A nal. Chem., 81, 809-819.
134. Turteltaub, K.W., Felton, J.S., Gledhill, B.L., Vogel, J.S., Southon, J.R., Caffee, M.W., Finkel, R.C., Nelson, D.E., Proctor, I.D., and Davis, J.C. (1990) Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA. Proc. Natl. Acad. Sci. USA, 87, 5288-5292.
135. Lin, D., Kaderlik, K.R., Turesky, R.J., Miller, D.W., Lay, J.O., Jr., and Kadlubar, F.F. (1992) Identification of N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo [4,5-b ]pyridine as the major adduct formed by the food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine, with DNA. Chem. Res. Toxicol., 5, 691-697.
136. Ghoshal, A., Davis, C.D., Schut, H.A.J., and Snyderwine, E.G. (1995) Possible mechanisms for PhIP-DNA adduct formation in the mammary gland of female Sprague-Dawley rats. Carcinogenesis, 16, 2725-2731.
137. Lin, D.-X., Meyer, D.J., Ketterer, B., Lang, N.P., and Kadlubar, F.F. (1994) Effects of human and rat glutathione-S-transferase on the covalent binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. Cancer Res., 54, 4920-4926.
138. Malfatti, M.A. and Felton, J.S. (2004) Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro. Chem. Res. Toxicol., 17, 1137-1144.
139. Talaska, G., al Juburi, A.Z., and Kadlubar, F.F. (1991) Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc. Natl. Acad. Sci. USA, 88, 5350-5354.
140. Wang, L.Y., Chen, C.J., Zhang, Y.J., Tsai, W.Y., Lee, P.H., Feitelson, M.A., Lee, C.S., and Santella, R.M. (1998) 4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am. J. Epidemiol., 147, 315-323.
141. Besaratinia, A., Van Straaten, H.W., Kleinjans, J.C., and Van Schooten, F.J. (2000) Immunoperoxidase detection of 4-aminobiphenyl-and polycyclic aromatic hydrocarbons-DNA adducts in induced sputum of smokers and non-smokers. Mutat. Res., 468, 125-135.
142. Flamini, G., Romano, G., Curigliano, G., Chiominto, A., Capelli, G., Boninsegna, A., Signorelli, C., Ventura, L., Santella, R.M., Sgambato, A., and Cittadini, A. (1998) 4-Aminobiphenyl-DNA adducts in laryngeal tissue and smoking habits: an immunohistochemical study. Carcinogenesis, 19, 353-357.
143. Ambrosone, C.B., Abrams, S.M., Gorlewska-Roberts, K., and Kadlubar, F.F. (2007) Hair dye use, meat intake, and tobacco exposure and presence of carcinogen-DNA adducts in exfoliated breast ductal epithelial cells. Arch. Biochem. Biophys., 464, 169-175.
144. Zayas, B., Stillwell, S.W., Wishnok, J.S., Trudel, L.J., Skipper, P., Yu, M.C., Tannenbaum, S.R., and Wogan, G.N. (2007) Detection and quantification of 4-ABP adducts in DNA from bladder cancer patients. Carcinogenesis, 28, 342-349.
145. Ricicki, E.M., Soglia, J.R., Teitel, C., Kane, R., Kadlubar, F., and Vouros, P. (2005) Detection and quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human pancreas tissue using capillary liquid chromatography-microelectrospray mass spectrometry. Chem. Res. Toxicol., 18, 692-699.
146. Totsuka, Y., Fukutome, K., Takahashi, M., Takashi, S., Tada, A., Sugimura, T., and Wakabayashi, K. (1996) Presence of N 2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f ]quinoxaline (dG-C8-MeIQx) in human tissues. Carcinogenesis, 17, 1029-1034.
147. Friesen, M.D., Kaderlik, K., Lin, D., Garren, L., Bartsch, H., Lang, N.P., and Kadlubar, F.F. (1994) Analysis of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine in rat and human tissues by alkaline hydrolysis and gas chromatography/electron capture mass spectrometry: validation by comparison with 32 P-postlabeling. Chem. Res. Toxicol., 7, 733-739.
148. Magagnotti, C., Pastorelli, R., Pozzi, S., Andreoni, B., Fanelli, R., and Airoldi, L. (2003) Genetic polymorphisms and modulation of 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine (PhIP)-DNA adducts in human lymphocytes. Int. J. Cancer, 107, 878-884.
149. Coles, B.F. and Kadlubar, F.F. (2003) Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors, 17, 115-130.
150. Zhu, J., Chang, P., Bondy, M.L., Sahin, A.A., Singletary, S.E., Takahashi, S., Shirai, T., and Li, D. (2003) Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., 12, 830-837.
151. Gorlewska-Roberts, K., Green, B., Fares, M., Ambrosone, C.B., and Kadlubar, F.F. (2002) Carcinogen-DNA adducts in human breast epithelial cells. Environ. Mol. Mutagen., 39, 184-192.
152. Tang, D., Liu, J.J., Rundle, A., Neslund-Dudas, C., Savera, A.T., Bock, C.H., Nock, N.L., Yang, J.J., and Rybicki, B.A. (2007) Grilled meat consumption and PhIP-DNA adducts in prostate carcinogenesis. Cancer Epidemiol. Biomarkers Prev., 16, 803-808.
153. Lightfoot, T.J., Coxhead, J.M., Cupid, B.C., Nicholson, S., and Garner, R.C. (2000) Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine and benzo[ a ]pyrene. Mutat. Res., 472, 119-127.
154. Bogen, K.T. and Keating, G.A. (2001) US dietary exposures to heterocyclic amines. J. Expo. Anal. Environ. Epidemiol., 11, 155-168.
155. Sinha, R. (2002) An epidemiologic approach to studying heterocyclic amines. Mutat. Res., 506-507, 197-204.
156. Luo, W., Fan, W., Xie, H., Jing, L., Ricicki, E., Vouros, P., Zhao, L.P., and Zarbl, H. (2005) Phenotypic anchoring of global gene expression profiles induced by N-hydroxy-4-acetylaminobiphenyl and benzo[ a ]pyrene diol epoxide reveals correlations between expression profiles and mechanism of toxicity. Chem. Res. Toxicol., 18, 619-629.